SBIR-STTR Award

3D Markerless Motion Capture Technology for Gait Analysis
Award last edited on: 3/23/2023

Sponsored Program
SBIR
Awarding Agency
NSF
Total Award Amount
$1,259,598
Award Phase
2
Solicitation Topic Code
MD
Principal Investigator
Andrew Ekelem

Company Information

Evolution Devices Inc (AKA: Foot++ Inc)

2150 Shattuck Avenue Fl Ph
Berkeley, CA 94704
   (661) 993-0685
   N/A
   www.evolutiondevices.com
Location: Single
Congr. District: 12
County: Alameda

Phase I

Contract Number: 2014869
Start Date: 7/1/2020    Completed: 4/30/2021
Phase I year
2020
Phase I Amount
$224,990
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to advance diagnosis and treatment of walking disorders and associated rehabilitation. An estimated 50 million Americans experience gait (walking) impairment due to injury, disease, and age, and more than 38,800 physical therapy clinics treat these patients. This project will develop an artificial intelligence system to extract gait metrics from video data from cameras surrounding a small area. A new diagnostic tool will track nuanced gait metrics throughout rehabilitation treatment. This technology will enable new and faster ways for physical therapists to precisely diagnose gait abnormalities and track treatment.This Small Business Innovation Research (SBIR) Phase I project could result in a system to diagnose gait deficiencies for people who suffer from neurological impairments. The proposed project will develop a markerless three-dimensional motion capture system to accurately diagnose gait pathologies in a time- and cost-efficient manner for clinicians. The project will: validate of the markerless motion capture system to ensure accurate measurement of raw kinematic metrics within 10% error of standard methods and potentially expand the system metrics; and conduct verification and validation processes.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

Phase II

Contract Number: 2153138
Start Date: 6/1/2022    Completed: 5/31/2024
Phase II year
2022
(last award dollars: 2023)
Phase II Amount
$1,034,608

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project benefitd the 70 million people struggling with gait disorders in the US. Gait analysis monitors how individuals walk to predict or prevent injuries and track rehabilitation progress. Due to the potentially high equipment costs, space requirements, and required technical expertise to collect and interpret results, detailed gait analyses are limited to a few centers and mainly used for surgical decision-making. This project uses Artificial Intelligence (AI) for gait analysis at roughly 70% less than typical costs, as well as offering reduced set-up time and improved workflow efficiency.The proposed project will address the existing technological and commercial barriers that make gait analysis an exclusive clinical tool restricted to only 300 gait labs across the country. This project will develop a cost-effective markerless motion 3D-tracking system. Technical activities include: (1) increase the motion database to a diverse population, including children and patients with mobility impairments; (2) improve the computer vision algorithms to account for multiple individuals within the camera system’s field of view; (3) integrate EMG and Force Plates; (4) implement skeletal geometry estimation from computed tomography; (5) develop a self-calibration system that can operate with HD low cost cameras; and (5) improve accuracy and usability substantially to reduce the expertise required for computational gait analysis.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.